NEUROSOFT MEDICAL DIAGNOSTIC EQUIPMENT
LIVE

Serial Number

79254130

Owner

Neurosoft Llc

Filing Date

Jul 30, 2018

Add to watchlist:

No watchlists yet
View on USPTO

NEUROSOFT MEDICAL DIAGNOSTIC EQUIPMENT Trademark

Serial Number: 79254130 • Registration: 5899757

NEUROSOFT MEDICAL DIAGNOSTIC EQUIPMENT is a trademark filed by Neurosoft Llc on July 30, 2018. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Neurosoft Llc

Voronin str., 5

Entity Type: 16

Trademark Details

Filing Date

July 30, 2018

Registration Date

November 5, 2019

Published for Opposition

August 20, 2019

Cancellation Date

May 22, 2026

Goods & Services

Computer software for operating therapeutic, diagnostic and rehabilitation medical systems; Computer software in the field of data management for processing medical data, patient data, and demographic data, namely, data acquisition, data visualization, automatic data analysis, statistic data analysis, automated report generation, comparative data analysis, data export/import, data searching, data synchronization tools

Medical devices for performing clinical electroencephalography, video electroencephalography, long-term monitoring, polysomnography, cardiorespiratory monitoring, cerebral function monitoring, electroencephalography in intensive care unit, multimodality long-latency, middle-latency and short-latency evoked potential testing, and therapy with biological feedback methods; medical devices for performing electromyography, nerve conduction studies, electroretinography, ultrasound study to perform ultrasound imaging of nervous and muscles; medical diagnostic equipment for use in neurosurgery, orthopedics and spinal surgery, vascular and ENT surgery, namely, instruments and component parts therefor for stimulating, measuring, recording, localizing and/or monitoring the electrical and/or physiological activity of the nerves, brain and muscles; diagnostic and therapeutic apparatus for medical purposes, namely, magnetic stimulators for the stimulation of muscles, nerves and brain tissue using a magnetic field; medical apparatus, namely, coils for use with magnetic stimulators; medical devices and instruments for monitoring, recording, storing, analysis, and remote transmission of patient's electrocardiogram at rest and during various activities including electrocardiographs, ambulatory monitors, exercise stress test systems, cardiopulmonary testing systems, cardiac rehabilitation systems, systems for autonomic nervous system assessment, remote patient monitoring systems; medical audiological apparatus for medical diagnostic, screening and research of hearing and balance functions, measuring hearing loss, as well as degree and type of hearing loss, namely, audiometers, tympanometers, auditory brainstem response and auditory evoked potential analyzers, otoacoustic emission analyzers, vestibular testing and rehabilitation instruments, otoscopes and videootoscopes, and parts and fittings for all the aforesaid goods; medical apparatus for testing and fitting hearing aids, namely, hearing aid test chambers, real ear measurement systems, and parts and fittings for all the aforesaid goods; medical equipment for performing spirometry tests, rheography tests; medical equipment for motion rehabilitation in the upper and lower limbs and spine, diagnostics of movement disorders, electrical stimulation, sports biomechanics screening of athletes for predicting injury risk, analysis of motion performance in sports, and use during sports training, and stabilometrics analysis of handstands and balance testing; medical apparatus and instruments for comprehensive assessment of the psychophysiological and psychological state and functions in healthy individuals and also in patients with disorders based on the result of the tests and analysis of the parameters of obtained electrophysiological signals; medical device, namely, portable electrical stimulator for localization of sites of medication injection, by means of EMG recording and electrical stimulation and intraoperative localization of muscle topography, for treatment of urinary incontinence using electrical stimulation; medical device, namely, electrical stimulator intended for non-invasive transcranial stimulation with electrical current for the transcutaneous stimulation of the spine and peripheral nervous structures for the purpose of neuromodulation

Filing History

CANCELLED SECTION 71
May 22, 2026 C71T
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 21, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 28, 2020 FICS
FINAL DISPOSITION PROCESSED
Feb 28, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 5, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 5, 2019 R.PR
NOTIFICATION PROCESSED BY IB
Aug 23, 2019 GPNX
PUBLISHED FOR OPPOSITION
Aug 20, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 7, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 7, 2019 OP2R
NOTICE OF PUBLICATION
Jul 31, 2019 NPUB
ASSIGNED TO LIE
Jul 12, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 14, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 14, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 14, 2019 ERFR
FINAL REFUSAL MAILED
Jun 11, 2019 CNFR
FINAL REFUSAL WRITTEN
Jun 11, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 17, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 17, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 17, 2019 TROA
REFUSAL PROCESSED BY IB
May 10, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 25, 2019 RFCS
REFUSAL PROCESSED BY MPU
Apr 25, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 4, 2019 RFCR
NON-FINAL ACTION WRITTEN
Apr 3, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 29, 2019 MAFR
ASSIGNED TO EXAMINER
Mar 25, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 25, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 18, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 14, 2019 REPR